Datavault AI Inc.
Corporate brand
UnclaimedDatavault AI Inc. is a technology company brand name; the supplied evidence does not describe its business.
Last updated October 30, 2026
AI crawler reads
No AI crawler has read this profile yet.
Overview
Datavault AI Inc. appears in this dossier only as a company/brand name. The single piece of supplied evidence (E1) is a press release about Debiopharm's antibody-drug-conjugate linker research and contains no information about Datavault AI Inc. — no products, services, ownership, headquarters, founding details, or market activity. Because the evidence does not support any substantive brand claims, this entry is intentionally kept short and flagged for review. It should be re-researched against Datavault AI's own official website, securities filings, and press releases before being used as a knowledge-base record.
Recent events
Reported
Datavault AI appoints Jeffrey Tirman to its Board of Directors[2]
Datavault AI Inc. (Nasdaq: DVLT) announced the appointment of Jeffrey Tirman, a shareholder and investment executive holding 26 million DVLT shares through his family office Abri Capital Ltd., to its Board of Directors, effective as of October 12, 2026. Tirman was designated by NYIAX, Inc. in connection with Datavault AI's recently completed acquisition of NYIAX, and he previously served on NYIAX's board of directors.
Sources2 sources
Cite this profile: Cite the canonical profile. /brand-wiki/datavault-ai-inc · Editorial policy · How profiles are compiled